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Abstract 
Opioid related deaths are increasing dramatically in recent years, and opioid epidemic is worsening in the United 
States. Combating opioid epidemic becomes a high priority for both the U.S. government and local governments such 
as New York State. Analyzing patient level opioid related hospital visits provides a data driven approach to discover 
both spatial and temporal patterns and identity potential causes of opioid related deaths, which provides essential 
knowledge for governments on decision making. In this paper, we analyzed opioid poisoning related hospital visits 
using New York State SPARCS data, which provides diagnoses of patients in hospital visits. We identified all patients 
with primary diagnosis as opioid poisoning from 2010-2014 for our main studies, and from 2003-2014 for temporal 
trend studies. We performed demographical based studies, and summarized the historical trends of opioid poisoning. 
We used frequent item mining to find co-occurrences of diagnoses for possible causes of poisoning or effects from 
poisoning. We provided zip code level spatial analysis to detect local spatial clusters, and studied potential 
correlations between opioid poisoning and demographic and social-economic factors. 
Introduction 
The United States is experiencing an epidemic of opioid related deaths. Since 2000, the rate of deaths from drug 
overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids1. Given 
these alarming trends, combating opioid epidemic becomes a high priority for both the US government and local 
governments such as New York State. For example, the U.S. Department of Health and Human Services (HHS) has 
implemented evidence-based approaches to reduce opioid overdoses and the prevalence of opioid use disorder2. The 
MOON (Maximizing OpiOid safety with Naloxone) study tries to find out more information about the public's 
perception of opioid safety, naloxone distribution, and the use of the pharmacy as an integral site for public health 
intervention3. 
With increased accessibility of health data driven by open data initiatives, large-scale patient level data analysis 
provides an opportunity of data driven approach to identity patterns of opioid epidemic and discover potential causes 
of opioid related deaths through studying large scale diagnoses from hospital visits.  This will provide quantitative 
measurements and essential knowledge to support the governments for decision making on prevention, treatment, 
recovery and enforcement. Analyzing opioid data at fine spatial resolutions such as zip code can also reveal 
community level distribution patterns in terms of demography, regions and historical trends, which will provide crucial 
knowledge for residents, schools, businesses and health and human service professionals for seeking solutions.  
As part of New York State’s open data initiative, New York State Statewide Planning and Research Cooperative 
System (SPARCS) 6 collects patient level details on patient characteristics, diagnoses and treatments, services, and 
charges for each inpatient stay and outpatient visit (emergency department, ambulatory surgery, and outpatient 
services). It also includes locations of patients (street addresses). Researchers can benefit from SPARCS data by 
leveraging patients’ diagnosis histories, co-occurrences of diagnoses (primary and secondary ones), and location. Such 
unprecedented amounts of patient records make it possible for us to explore opioid poisoning in New York State with 
significant improvement of accuracy and coverage compared to prior studies on opioid abuse at global level4 or urban 
level5. 
In this paper, we provide large scale analysis of opioid poisoning based on SPARCS data. We extract all patient 
records with opioid poisoning related primary diagnosis codes from all visits (inpatients, outpatients, emergency and 
ambulatory surgeries) from year 2010-2014 for our main studies, and from year 2003-2014 for temporal trend studies. 
We aim at four types of studies: 1) demographical based studies to explore disparities between population groups; 2) 
historical trends of opioid poisoning;  3) co-occurrence based studies to discover possible causes of opioid poisoning 
or effects from opioid poisoning; and 4) spatial analysis (zip code level) to explore potential local spatial clusters, and 
potential correlations between opioid poisoning and demographic and social-economic factors.  
 
  
Methods 
Data Sources 
SPARCS Data. In this work, we used hospital discharge data from New York State SPARCS6. Any New York State 
healthcare facility certified to provide inpatient services, ambulatory surgery services, emergency department services 
or outpatient services is required to submit data to SPARCS. The purpose of SPARCS was to create a statewide data 
set to contribute to the goal of providing high quality medical care by serving as an information source7. 
Opioid Poisoning Hospital Visits. While the SPARCS data contains a comprehensive list of diagnosis and treatment 
procedure codes for each discharge record, this paper focused on analyzing patient level patterns of opioid poisoning 
hospital visits.  
In SPARCS data, each hospital discharge record contains only one primary diagnosis code. Each record also contains 
one or more optional secondary diagnosis codes that include all conditions that coexisted at the time of admission, or 
developed subsequently, which affected the treatment received and/or length of stay7. 
In this work, we generated a subset of the SPARCS data using selected the International Classification of Diseases 9 
(ICD-9) codes (also called billing codes) that pertain to opioid poisoning diagnoses, for both inpatient stays and 
outpatient visits (including emergency department visits, ambulatory surgery, and outpatient visits). We extracted 
opioid poisoning hospital visits by filtering the discharge records with their primary diagnosis code as the selected 
opioid poisoning ICD-9 codes. 
The selected ICD-9 codes were a collection of poisonings by opiates, opium, heroin, methadone, and other related 
narcotics, including 9650 (Poisoning; Opiates and Related Narcotics), 96500 (Poisoning; Opium/alkaloids, 
unspecified), 96501 (Poisoning; Heroin), 96502 (Poisoning; Methadone), 96509 (Poisoning; Other opiates and related 
narcotics), E8500 (Accidental Poisoning; Heroin), E8501 (Accidental Poisoning; Methadone), and E8502 (Accidental 
Poisoning; Other Opiates and Related Narcotics). 
Table 1. Demographics of patients with opioid related hospital visits, New York State, 2010-2014. 
 
New York State Population* Patients with Opioid Poisoning Hospital Visits 
19,594,330 24,161 
Age 
and 
Sex 
Under 5 years 6.0% 1.3% 
5 to 14 years 12.0% 0.6% 
15 to 44 years 41.0% 56.4% 
45 to 64 years 26.7% 32.6% 
65 and over 13.5% 9.0% 
 Male persons 48.5% 60.0% 
 Female persons 51.5% 40.0% 
Race 
and 
Ethnic 
White alone 65.0% 72.2% 
African American alone 15.6% 11.3% 
Asian alone 7.8% 0.5% 
Hispanic or Latino 18.2% 8.8% 
* 2010-2014 American Community Survey (ACS) 5-year estimates  
Patients’ Residential ZIP Codes and Hospital Admission Years. We conducted analyses at ZIP code level with basic 
demographics for the year 2010-2014 given in Table 1. We approximated patients’ home location by combining the 
5-digit ZIP code number with the patients’ home address and geographic data from TIGER/LINE data8. We then 
aggregated opioid poisoning hospital visits at ZIP code level (Figure 1) and generated opioid poisoning incidence rates 
for the following spatial and temporal analyses (Figure 4-5).  
For temporal trend studies, we used the hospital admission year for the time range 2005-2014 for inpatient stays and 
2003-2014 for emergency department visits (Figure 3). 
  
Analysis Methods 
Opioid Poisoning Incidence Rates 
We counted opioid poisoning patients with at least one opioid poisoning hospital at ZIP code level as shown in Figure 
1. The opioid poisoning incidence rates by ZIP code were calculated through dividing counts of patients with opioid 
poisoning hospital visits by ZIP level population counts from Census data. In this paper, we evaluated both statewide 
rate and rates at ZIP code level. The incidence rates provided useful information about how common a disease is when 
compared to other diseases, or how common a disease in a specific location is as compared to the global baseline. 
Frequent Co-Occurrence Patterns 
Disease co-occurrence, also known as comorbidity9-10 in public health studies, may imply the potential association 
across different types of diseases. The comorbidity is the presence of one or more additional diseases or disorders co-
occurring with a primary disease or disorder18. 
We explored frequent disease co-occurrence patterns to find the frequent disease diagnoses that co-exist with opioid 
poisoning diagnoses. We first ranked all the secondary diagnosis codes by their counts in all the opioid poisoning 
hospital visits (Table 2). We then use Apriori-like algorithm11 to discover top co-occurrences of diseases for opioid 
poisoning diagnoses (Table 3).  
Apriori Algorithm is a common data mining technique to identify co-occurrences or temporal patterns between 
diseases in clinical domain12. This work tried to adopt Apriori algorithm to identify comorbidities among hospital 
visits. Apriori algorithm discovers frequent comorbidities by comparing their supports with a user-specified minimum 
support threshold.  
For example, if the support of comorbidity pattern {96500 Poisoning by opium, 9670 Poisoning by barbiturates} (in 
Table 3) is 0.002, it means that 0.2% of all hospital visits have this comorbidity pattern. If the minimum support 
threshold is greater than 0.2%, this pattern will not be identified. However, if the minimum support threshold is set 
smaller than 0.2%, the comorbidity pattern will be extracted. In this work, we set the minimum support threshold as 
0.1%. 
 
Figure 1. Counts of Patients with Opioid Poisoning Hospital Visits by Zip Code, New York State, 2010-2014. 
Spatial Clustering 
To test whether there is global spatial clustering tendency for opioid poisoning incidence rate or other spatial impact 
factors, we used Moran’s I (Tables 4) 13. Moran’s I is a widely used global cluster test, which determines the degree 
  
of clustering or dispersion within a data set. The test result may range from 1 (perfect correlation), 0 (complete spatial 
randomness) to -1 (perfect dispersed). For the opioid poisoning incidence rate, a positive spatial autocorrelation means 
that the ZIP code areas with high rate are close to other areas with high rates. 
In addition to the global cluster test (with Moran’s I index in Table 4) and visual analysis for mapping raw counts of 
opioid poisoning incidence (in Figure 1), we also took cluster and outlier analysis with Anselin Local Moran’s I 
statistics13 to quantitatively detect local clusters for opioid poisoning incidence rates (Figure 4). The Anselin Local 
Moran's I statistics is a local cluster test that, given a set of weighted features, identifies statistically significant hot 
spots, cold spots, and spatial outliers. 
Spatial Regression 
To identify potential correlations between diseases and spatial impact indicators, we assessed both non-spatial and 
spatial correlation13. Ordinary least square regression analyses (OLS) was used to determined non-spatial correlation 
between opioid poisoning and demographic/socio-economic factors. We then used Geographically Weighted 
Regression (GWR) to assess the spatially varying relationship at a local level. 
OLS is a linear regression method that closely fits a function by minimizing the sum of squared errors. To determine 
potential candidate factors, we evaluated several possible factor combinations that form a properly specified OLS 
regression model. GWR is a local form of linear regression used to model spatially varying relationships. To evaluate 
the correlation between opioid poisoning and spatial impact factors accounting for data in surrounding areas, we then 
conducted GWR with a selected spatial impact factor based on OLS results. Specifically, a fixed kernel type function 
was used to calculate the GWR regression coefficients. The extent of the kernel is determined using the Akaike 
Information Criterion (AICc)14-15. 
Results 
Demographic-based Analysis 
Table 1 compared the demographics between New York State population and patients with opioid poisoning during 
2010-2014. The overall opioid poisoning incidence rate in New York State was 12.33 per 10,000 persons per five 
years. The percentage of female in New York State were 51.5% compared with only 40.0% of female patients with 
opioid poisoning, suggesting that female was less likely to have opioid poisoning hospital visits.  
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Figure 2. The age distribution of opioid poisoning in New York State, 2010-2014. 
Comparing different race and ethnicity groups, we can see significant disparities between racial-ethnic proportions in 
patient and general population. Whites made 72.2% of patients that was higher than the whites proportion in general 
population. On the contrary, Asians had a very low percentage of patients that may require further investigation for 
the specific causes. 
Figure 2 showed the age distribution of opioid poisoning in New York State, 2010-2014. We found a peak of opioid 
poisoning among young adults aged 21 to 25. Prior work has shown an increasing trend of adolescents and young 
adults with prescription drugs misuse16-17. Our statistics on age for opioid poisoning hospital visits (Figure 2) was 
consistent with the prior national-wide survey. 
Temporal Trends 
Outpatient emergency departments (EDs) and inpatient stays play an important role in the treatment of drug poisoning. 
For the period of most recent year available 2010-2014, both opioid poisoning hospital EDs and inpatient stays 
continued to increase in the United States, as is true for New York State from our results. Statewide, there were 4,238 
outpatient ED visits and 2,909 inpatient stays in 2014, a 116.4 percent increase and a 17.3 percent increase respectively 
from 2010.  
Figure 3 showed temporal trends of the proportion of opioid poisoning hospital visits for the past decade. While we 
found a modest rising trend for inpatient stays, there was an increasingly rising trend for outpatient EDs. 
 
Figure 3. Temporal trends of the proportion of opioid poisoning hospital visits, New York State, 2003-2014. 
Frequent Co-Occurrence Patterns 
We used frequent item mining to find co-occurrences of diagnoses for possible causes of poisoning or effects from 
poisoning. We used all ICD-9 diagnosis codes from opioid poisoning hospital discharge records. The diagnosis codes 
mark medical conditions, such as chronic ischemic heart disease, pure hypercholesterolemia, type 2 diabetes, and 
many other types of diseases.  
Table 2 presented the top 20 diagnosis codes that co-existed with opioid poisoning diagnoses by their total counts in 
all opioid poisoning discharge records. 
We found several diagnoses that were the well-established comorbidities of opioid dependence. For example, opioid 
use disorder is often associated with other substance use disorders, such as tobacco, alcohol and benzodiazepines, 
which are often taken to reduce symptoms of opioid withdrawal or craving for opioids, or to enhance the effects of 
administered opioids. Individuals with opioid use disorder are also at risk for the development of mild to moderate 
depression. Periods of depression are especially common during chronic intoxication or in association with physical 
or psychosocial stressors that are related to the opioid use disorder.18 
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As we didn’t find any infection disease among the top co-existed diagnoses in Table 2, most of the opioid poisoning 
hospital visits may come from patients with prescription opioids. Usually, the most common medical conditions 
associated with opioid use disorder are viral (e.g., HIV, hepatitis C virus) and bacterial infections, particularly among 
users of opioids by injection. These infections are less common in opioid use disorder with prescription opioids.18  
The other co-existed diagnoses listed in Table 2 should be the effects from opioid poisoning, including acute 
respiratory failure, acute kidney failure, pneumonitis, hypopotassemia, and rhabdomyolysis. 
Table 2. Top 20 Co-existed Diagnosis Codes of Opioid Poisoning Hospital Visits. 
Code Description Rank Code Description Rank 
3051 Tobacco Use Disorder 1 5849 Acute Kidney Failure, Unspecified 11 
4019 Unspecified Essential Hypertension 2 25000 Diabetes Mellitus Without Mention Of Complication 
12 
311 Depressive Disorder, Not Elsewhere Classified 
3 30000 Anxiety State, Unspecified 13 
30550 Opioid Abuse, Unspecified 4 5070 Pneumonitis Due To Inhalation Of Food Or Vomitus 
14 
51881 Acute Respiratory Failure 5 30500 Alcohol Abuse, Unspecified 15 
30401 Opioid Type Dependence, Continuous 
6 30590 Other, Mixed, Or Unspecified Drug Abuse, Unspecified 
16 
9694 Poisoning By Benzodiazepine-Based Tranquilizers 
7 2768 Hypopotassemia 17 
78097 Altered Mental Status 8 33829 Other Chronic Pain 18 
78009 Other Alteration Of Consciousness 9 49390 Asthma, Unspecified Type, Unspecified 
19 
30400 Opioid Type Dependence, Unspecified 
10 72888 Rhabdomyolysis 20 
 
Table 3. Top Co-existed diagnosis codes for different types of opiates and related narcotics. 
Opioid poisoning Diagnosis Code and Description 
Co-existed Diagnosis 
Code Description Support 
96500 Poisoning; Opium (alkaloids) 
9670 Poisoning By Barbiturates 0.002 
9679 Poisoning By Unspecified Sedative Or Hypnotic 0.001 
96501 Poisoning; Heroin 
30550 Opioid Abuse, Unspecified 0.074 
30551 Opioid Abuse, Continuous 0.012 
97081 Poisoning By Cocaine 0.009 
9708 Poisoning by other specified central nervous system stimulants 0.009 
4275 Cardiac Arrest 0.006 
96502 Poisoning; Methadone E8501 Accidental Poisoning; Methadone 0.002 
96509 Poisoning; Other opiates and related narcotics 
33829 Other Chronic Pain 0.027 
7245 Backache, Unspecified 0.019 
9654 Poisoning By Aromatic Analgesics 0.013 
7242 Lumbago 0.013 
2720 Pure Hypercholesterolemia 0.009 
  
 
Table 3 presented the top co-existed diagnoses for poisoning by different substance. Poisoning by heroin should be 
mainly caused by drug abuse as it generally co-existed with opioid abuse and resulted in a life-threating cardiac arrest. 
Poisoning by opium more likely co-existed with poisoning by barbiturates or other sedative-hypnotic drugs. On the 
other hand, poisoning by methadone mainly co-existed with accidental poisoning by methadone. Such findings may 
require further research for the potential driving factors. 
Spatial Analysis 
In this section, we performed zip code level spatial analysis to detect local spatial clusters, and studied potential 
correlations between opioid poisoning and demographic and social-economic factors.   
Figure 4 demonstrated the results of spatial clusters and outliers. The cluster/outlier type field distinguishes between 
a statistically significant cluster of high values (High-High cluster), cluster of low values (Low-Low cluster), outlier 
in which a high value is surrounded by low values (High-Low outlier), and outlier in which a low value is surrounded 
by high values (Low-High outlier). Statistical significance is set at the 95 percent confidence level. We applied the 
False Discovery Rate (FDR) correction to reduce this p-value threshold from 0.05 to a value that better reflects the 95 
percent confidence level given multiple testing. The FDR procedure will potentially reduce the critical p-value to 
account for multiple testing and spatial dependency.13 
 
Figure 4. Spatial clusters and outliers of opioid poisoning incidence rate by ZIP code, New York State, 2010-2014. 
We found that most areas of New York City had lower opioid poisoning hospital visits (Low-Low clusters in blue 
color) except several scattered high risk areas. Such findings were consistent with the decreasing trend of opioid 
overdose19 in New York City and the steep rise in opioid hospital visits outside New York City20. Targeted public 
health interventions might be effective in lowering opioid overdose mortality rates19. However, a small part of Staten 
Island and most part of southeastern Long Island were identified as high risk areas (High-High clusters in red color). 
  
For the scattered outliers across New York City (High-Low outlier or Low-High outlier), further investigation and 
intervention efforts may be required in the future. 
The spatial clustering analysis tried to answer the question of “where” by identifying potential high or low risk areas. 
The following question should be finding out why there were higher or lower opioid poisoning hospital visits at the 
discovered spatial clusters or outliers. We then used spatial regression analysis by linking  demographic and socio-
economic factors to opioid poisoning.  
We did exploratory regression analyses between the opioid poising and exemplary demographic and socio-economic 
factors as shown in Table 4. Among the 13 spatial impact factors, the OLS regression results showed that household 
income, Asian population and the youth population age 20 to 24 had most significant negative correlation relationship 
with the opioid poisoning.  
We then used GWR to model the local trends of correlation relationship between household income and opioid 
poisoning rates. The local coefficient map in Figure 5 showed that urban residents who made more money had lower 
rates of opioid poisoning, while country residents with higher income tended to had higher rates of opioid poisoning. 
Table 4. Statistics of demographic and socio-economic factors by ZIP Code in New York State, 2010-2014. 
Spatial Impact 
Factors 
Mean  
(Std. Error) Moran’s I Index 
Opioid Poisoning Incidence Rate per 
1,000 1.68 (2.02) 0.09 
 
Demographic  
Factors 
% Male  49.61 (5.41) 0.07 
% Age 15-19 years 6.73 (4.32) 0.07 
% Age 20-24 years 6.47 (4.06) 0.14 
% Age 25-34 years 11.71 (5.39) 0.44 
% Age 35-44 years 12.27 (3.74) 0.13 
% White 78.25 (25.22) 0.73 
% Black 6.89 (14.14) 0.63 
% Asian 3.69 (7.01) 0.72 
% Hispanic 8.90 (12.63) 0.69 
Socio-economic 
Factors 
Household Income  
($10,000 US) 
76,934 (35,610) 0.63 
% Poverty  12.5 (10.01) 0.43 
% Uninsured 9.15 (5.59) 0.30 
 
Discussion 
There has long been a demand for large-scale data driven approach to discover both spatial and temporal patterns and 
identity potential causes of diseases. This study provided our preliminary results of a large-scale patient level study 
on opioid poisoning hospital visits in the New York State. We examined the demographic disparities for the patients 
with opioid poisoning. We compared the historical trends of opioid poisoning for hospital emergency departments 
visits and inpatient stays. We used frequent item mining to find co-occurrences of diagnoses for possible causes of 
poisoning or effects from poisoning. We performed zip code level spatial analysis to detect local spatial clusters, and 
studied potential correlations between opioid poisoning and demographic and social-economic factors.  
This work focuses on a large-scale study of opioid poisoning related hospital visits in New York State. We found that 
men were more likely to have opioid poisoning hospital visits than women. Whites made 72.2% of patients that was 
higher than the whites proportion in general population. Asians, however, had a very low percentage of patients. We 
also found a peak of opioid poisoning hospital visits for young adults (21 to 25, peak at 22). A second peak is for ages 
  
starting from middle age (46-55, peak at 51). We found several diagnoses that were well-established comorbidities of 
opioid dependence. The spatial clustering analysis showed that most areas of New York City had lower opioid 
poisoning hospital visit rates compared to that in areas outside New York City. The spatial regression results showed 
that urban residents who made more money had lower rates of opioid poisoning, while country residents with higher 
income tended to had higher rates of opioid poisoning. 
However, our results were based on the patients with their primary diagnosis as opioid poisoning. In our ongoing 
work, we will also include the patients with their secondary diagnosis as opioid poisoning. We will examine more 
types of disease diagnoses and treatments and provide multi-dimensional analysis by grouping patients per their 
demographic attributes. We will take advantage of the street level location information and the full history of each 
patient for more fine grained spatial and temporal analysis. For example, after geocoding the patient addresses into 
latitude and longitude coordinates, we will perform point based spatial clustering analysis. By mapping patients’ 
residential locations into census block group boundaries, we will link the health records with census data and study 
potential risk factors with fine-grained spatial resolutions. 
 
 
Figure 5. The choropleth map that visualizes Geographically Weighted Regression (GWR) local coefficient of 
household Income for opioid poisoning incidence rate by ZIP code in New York State, 2010-2014. 
Conclusion 
Increased accessibility of health data made available by the government provides unique opportunity for data driven 
discovery of disease patterns and identity potential causes of opioid related deaths. large-scale patient level analysis 
could provide new insights and create new forms of value to support governments on decision making. In this paper, 
we present our analytical results on opioid poisoning related hospital visits using New York State SPARCS data. Our 
results not only provide quantitative measurements on demographic-based distributions, and spatial and temporal 
trends, but also present top common co-occurrences of diagnoses with opioid poisoning, which provides a groundwork 
to study possible causes of poisoning and effects from poisoning. Our results provide essential knowledge and 
guidelines to support stake holders for improving prevention, intervention and recovery of opioid poisoning.  
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